Publish to Newswire
Add an EventFrom the Open-Publishing Calendar
From the Open-Publishing Newswire
Indybay Feature
Corrupt UC Regents Plot Privatization Of University through "public private partnerships"
The UC Regents at their meeting on November 15, 2012 plotted on how to turn UC's public research into private by public private partnerships with capitalists wanting to profit from drug development. These regents have personally profited from public funds being invested in stock and investments that they own. The California Attorney General Kamal Harris refuses to investigate and prosecute them for financial conflicts of interests.
UC Regents Plot Privatization Of University
The UC Regents and management including UC president Mark Yudof on
their November 15, 2012 meeting at UC Mission Bay in San Francisco
plotted on how to have more public private partnerships in research to
"benefit" UC and the drug company capitalists.
UC Regent Richard Blum who has personally profited from UC investments
in his companies and Sherry Lansing who is now the UC Regents Chair
pushed using UC public research institutions to push for new drugs that can be
patented for profit by private public parternships and said they wanted UC
to be more like Stanford.
Lansing also profited from UC investments in Qualcom which she has stock in.
For more information go to
UC Regents and For-Profit Education
http://reclaimuc.blogspot.com/2011/06/uc-regents-and-for-profit-education.html
UC Board Of Regents Chair Sherry Lansing Corporate Connections Profit From UC Investments
http://spot.us/pitches/337-investors-club-how-the-uc-regents-spin-public-funds-into-private-profit/story
Production Of United Public Workers For Education
http://www.upwa.info
The UC Regents and management including UC president Mark Yudof on
their November 15, 2012 meeting at UC Mission Bay in San Francisco
plotted on how to have more public private partnerships in research to
"benefit" UC and the drug company capitalists.
UC Regent Richard Blum who has personally profited from UC investments
in his companies and Sherry Lansing who is now the UC Regents Chair
pushed using UC public research institutions to push for new drugs that can be
patented for profit by private public parternships and said they wanted UC
to be more like Stanford.
Lansing also profited from UC investments in Qualcom which she has stock in.
For more information go to
UC Regents and For-Profit Education
http://reclaimuc.blogspot.com/2011/06/uc-regents-and-for-profit-education.html
UC Board Of Regents Chair Sherry Lansing Corporate Connections Profit From UC Investments
http://spot.us/pitches/337-investors-club-how-the-uc-regents-spin-public-funds-into-private-profit/story
Production Of United Public Workers For Education
http://www.upwa.info
For more information:
http://youtu.be/LOJShHZV77c
Add Your Comments
Comments
(Hide Comments)
UC Davis School of Medicine dean to step down-Scandal Over Drug "research activities involving human subjects"
UC Davis School of Medicine dean to step down
By Marjie Lundstrom
mlundstrom(at)sacbee.com
Published: Monday, Nov. 19, 2012 - 11:06 am
Last Modified: Monday, Nov. 19, 2012 - 11:46 am
http://www.sacbee.com/2012/11/19/4997462/uc-davis-school-of-medicine-dean.html
Amid intense scrutiny from federal regulators and her own administration, the dean of the UC Davis School of Medicine announced Monday she will be stepping down.
Dr. Claire Pomeroy, whose seven-year tenure as dean was marked by fiscal growth but also by medical and ethical controversies, said she will leave the university on June 30 at the close of the academic year, according to a news release from the university.
The departure of Pomeroy marks the second time in recent months that the dean of one of the university's landmark schools has stepped down.
In August, the dean of the College of Agricultural and Environmental Sciences, along with the executive associate dean, also tendered their resignations.
It was not immediately clear what lies ahead for Pomeroy, an expert in infectious diseases and a professor of internal medicine and microbiology and immunology. In a prepared statement, she said that she wishes to "move forward to the next phase of my career and have a national impact by contributing to the re-design of the health care system at this pivotal moment in our country's history."
Pomeroy came to the School of Medicine in 2003 as executive associate dean and became vice chancellor and dean in 2005.
A woman with a unique personal story - she spent her teenage years in foster care - Pomeroy presided over tremendous growth for the UC Davis School of Medicine, which tripled its outside research funding during the last decade.
However, problems with medical research in the neurological surgery department became the focus of multiple investigations in the past 18 months, as chronicled by The Sacramento Bee.
At issue is the work of two neurosurgeons, Dr. J. Paul Muizelaar and Dr. Rudolph J. Schrot, who were banned last year by the university from any research activities involving human subjects.
The doctors have been accused of experimenting on dying brain cancer patients without proper approval from university officials or from federal regulators. The case has placed an uncomfortable spotlight on the university as both the federal Centers for Medicare and Medicaid Services and the Joint Commission, which accredits hospitals, have opened investigations. The university's provost is also conducting a second internal probe.
Since July, when The Bee first reported the controversy involving Muizelaar and Schrot, Pomeroy has declined all requests to be interviewed on the matter.
Call The Bee's Marjie Lundstrom, (916) 321-1055.
UC Davis School of Medicine dean to step down
By Marjie Lundstrom
mlundstrom(at)sacbee.com
Published: Monday, Nov. 19, 2012 - 11:06 am
Last Modified: Monday, Nov. 19, 2012 - 11:46 am
http://www.sacbee.com/2012/11/19/4997462/uc-davis-school-of-medicine-dean.html
Amid intense scrutiny from federal regulators and her own administration, the dean of the UC Davis School of Medicine announced Monday she will be stepping down.
Dr. Claire Pomeroy, whose seven-year tenure as dean was marked by fiscal growth but also by medical and ethical controversies, said she will leave the university on June 30 at the close of the academic year, according to a news release from the university.
The departure of Pomeroy marks the second time in recent months that the dean of one of the university's landmark schools has stepped down.
In August, the dean of the College of Agricultural and Environmental Sciences, along with the executive associate dean, also tendered their resignations.
It was not immediately clear what lies ahead for Pomeroy, an expert in infectious diseases and a professor of internal medicine and microbiology and immunology. In a prepared statement, she said that she wishes to "move forward to the next phase of my career and have a national impact by contributing to the re-design of the health care system at this pivotal moment in our country's history."
Pomeroy came to the School of Medicine in 2003 as executive associate dean and became vice chancellor and dean in 2005.
A woman with a unique personal story - she spent her teenage years in foster care - Pomeroy presided over tremendous growth for the UC Davis School of Medicine, which tripled its outside research funding during the last decade.
However, problems with medical research in the neurological surgery department became the focus of multiple investigations in the past 18 months, as chronicled by The Sacramento Bee.
At issue is the work of two neurosurgeons, Dr. J. Paul Muizelaar and Dr. Rudolph J. Schrot, who were banned last year by the university from any research activities involving human subjects.
The doctors have been accused of experimenting on dying brain cancer patients without proper approval from university officials or from federal regulators. The case has placed an uncomfortable spotlight on the university as both the federal Centers for Medicare and Medicaid Services and the Joint Commission, which accredits hospitals, have opened investigations. The university's provost is also conducting a second internal probe.
Since July, when The Bee first reported the controversy involving Muizelaar and Schrot, Pomeroy has declined all requests to be interviewed on the matter.
Call The Bee's Marjie Lundstrom, (916) 321-1055.
For more information:
http://www.sacbee.com/2012/11/19/4997462/u...
We are 100% volunteer and depend on your participation to sustain our efforts!
Donate
$140.00 donated
in the past month
Get Involved
If you'd like to help with maintaining or developing the website, contact us.
Publish
Publish your stories and upcoming events on Indybay.
Topics
More
Search Indybay's Archives
Advanced Search
►
▼
IMC Network